SpyGlass Pharma, Inc. SGP
34.62 USD +0.17 (+0.49%)
Nov 4, 2026, 12:35 PM EST
34.18 Day range 35.75
17.06 52-week range 35.75
- YTD
- +31.14%
- 1 year
- +31.14%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 44.00 +27.1% upside
Now 34.62
- Target (low)
- 37.00
- Target (mean)
- 44.00
- Target (high)
- 62.00
Ratings (0m) 6 6 buy · 0 hold · 0 sell
- Strong buy1
- Buy5
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 6
- 1 month ago 6
- 2 months ago 6
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.62247 | -0.71 – -0.52481 | 0.00 | 0.0% | 0 | 0.0% | 6 |
| Next quarter | -0.65294 | -0.77 – -0.54762 | 0.00 | 0.0% | 0 | 0.0% | 6 |
| Current year | -2.50 | -2.57 – -2.31 | -1.96 | -27.5% | 0 | 0.0% | 6 |
| Next year | -2.81 | -3.45 – -1.95 | -2.50 | -12.6% | 0 | 0.0% | 6 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 21, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 5, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 14, 2026 | Raymond James | Initiated | — | Outperform |
| Mar 10, 2026 | HC Wainwright & Co. | Initiated | — | Buy |
| Mar 3, 2026 | Citigroup | Initiated | — | Buy |
| Mar 3, 2026 | Leerink Partners | Initiated | — | Outperform |
| Mar 3, 2026 | Jefferies | Initiated | — | Buy |
| Mar 3, 2026 | Stifel | Initiated | — | Buy |